Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-15

FDA Approved: TIROSINT SOL — Original Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved TIROSINT SOL (levothyroxine sodium) from IBSA Pharma Inc. in an original NDA, introducing a new brand/formulation of thyroid hormone replacement th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirosint-SOL (Levothyroxine sodium oral solution)

Snippet

ORIG AP for TIROSINT SOL (LEVOTHYROXINE SODIUM)